Veeva MedTech Transforming Clinical Trials for Medical Devices
Veeva MedTech Sets New Standards in Clinical Trials
In an evolving landscape, over 50 companies, including 11 of the top 20 in the medtech sector, are now harnessing the power of Veeva clinical applications. This shift aims to enhance efficiency and accelerate the speed of clinical trials, providing a solid foundation for future medical innovations.
Streamlining Clinical Research with Veeva
Veeva Systems (NYSE: VEEV) has announced that a diverse group of 50 medtech companies and leading clinical research organizations have embraced the Veeva Clinical Platform. This strategy is particularly pivotal in easing the burdens imposed by stringent regulatory standards and a fast-changing market. Medtech companies are increasingly discarding outdated approaches to embrace connected, modern applications offered by Veeva, which improve the process of managing medical device and diagnostics studies.
Improved Scalability and Compliance
With the Veeva Clinical applications, organizations can scale their clinical trial efforts without compromising on compliance with local and global regulations. Companies utilize Veeva solutions to expedite processes; customers report a remarkable 50% reduction in study build times through Veeva EDC tools and an 80% decrease in redundant trial documents leveraging the capabilities of Veeva eTMF.
Industry Sentiments and Collaborations
Kevin Liang, vice president of clinical strategy at Veeva MedTech, expressed enthusiasm about collaborating with industry leaders to establish a comprehensive framework for clinical trials concerning medical devices and diagnostics. This alliance seeks to refine study execution and promote innovation, ultimately facilitating quicker access to life-changing therapies for patients.
Testimonials from the Field
Professionals across the medtech landscape have shared their positive experiences with Veeva's offerings. For instance, Leianne Ebert, head of clinical data operations at Alcon, highlighted the advantages of Veeva EDC in enhancing the global library and creating reusable standards, achieving a significant 50% standardization increase within a year. Such enhancements have bolstered compliance across their global library.
Similarly, Kimberly Dorsch from LifeNet Health emphasized how Veeva ensures data collection aligns with regulatory acceptance. She noted that regardless of whether a study is registry-based or IDE/IND related, Veeva's framework allows for consistent and compliant data capture.
Matt Christensen from Smith+Nephew also remarked on the substantial improvements seen after implementing Veeva eTMF, noting a reduction of over 90% in quality control time and significant declines in document creation times.
About Veeva Systems and Its Commitment
Veeva Systems stands as the global leader in cloud-based software solutions tailored for the life sciences industry. With a mission centered on innovation and customer satisfaction, Veeva caters to over 1,000 clients, spanning from major biopharmaceutical corporations to emerging companies in biotech. As a Public Benefit Corporation, Veeva prioritizes the needs of all its stakeholders, including clients, employees, shareholders, and the industries it serves. Those interested in learning more about Veeva’s innovative Clinical Platform are encouraged to visit their website directly.
Frequently Asked Questions
What is Veeva MedTech?
Veeva MedTech is a division of Veeva Systems that focuses on providing clinical applications to enhance efficiency and compliance in medical device and diagnostics studies.
How does Veeva improve clinical trial efficiency?
Veeva improves efficiency by streamlining processes with its advanced applications, allowing companies to reduce study build times and eliminate redundant document creation.
What kind of companies use Veeva's solutions?
Over 50 medtech companies, including top global organizations, utilize Veeva’s applications to manage and optimize their clinical trial processes.
What are the benefits of using Veeva EDC?
Veeva EDC offers significant benefits such as faster study build times and improved compliance with regulatory standards, helping organizations achieve a 50% reduction in associated tasks.
Where can I learn more about Veeva's offerings?
For more information about Veeva's clinical applications tailored for the medtech industry, you can visit their official website.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.